Amryt Reports Record Q1 2021 Financial and Operating Results
Amryt Reports Record Q1 2021 Financial and Operating Results 8.7% YoY revenue growth in the quarter to $48.4M 16.5% YoY...
Month: May 2021
Galera to Participate in the BofA Securities 2021 Virtual Healthcare Conference
MALVERN, Pa., May 05, 2021 (GLOBE NEWSWIRE) -- Galera Therapeutics, Inc. (Nasdaq: GRTX), a clinical-stage biopharmaceutical company focused on developing...
ADMA Biologics to Report First Quarter 2021 Financial Results on May 12, 2021
Conference Call Scheduled for May 12, 2021 at 4:30 p.m. ETRAMSEY, N.J. and BOCA RATON, Fla., May 05, 2021 (GLOBE...
Annexon to Present at the BofA Securities 2021 Virtual Healthcare Conference
SOUTH SAN FRANCISCO, Calif., May 05, 2021 (GLOBE NEWSWIRE) -- Today Annexon, Inc. (“Annexon”) (Nasdaq: ANNX), a clinical stage biopharmaceutical...
Replimune Provides a Regulatory Update for its Registration- Directed Clinical Trials Evaluating RP1 in Combination with Libtayo® (cemiplimab) for the Treatment of CSCC & Evaluating RP1 in Combination with Opdivo® (nivolumab) in anti-PD1 Failed Melanoma
WOBURN, Mass., May 05, 2021 (GLOBE NEWSWIRE) -- Replimune Group, Inc. (Nasdaq: REPL), a biotechnology company developing oncolytic immuno-gene therapies...
Passage Bio Reports First Quarter 2021 Financial Results and Recent Business Highlights
Dosed first patient with infantile GM1 gangliosidosis in Imagine-1 Phase 1/2 trial of PBGM01, initial safety and 30-day biomarker data...
EyePoint Pharmaceuticals Reports First Quarter 2021 Financial Results and Highlights Recent Corporate Developments
- EYP-1901 DAVIO study for the potential treatment of wet AMD dosed first patient in January; study remains on...
Cyclacel Pharmaceuticals to Release First Quarter 2021 Financial Results and Provide Business Update
BERKELEY HEIGHTS, N.J., May 05, 2021 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; "Cyclacel" or the "Company"), a...
Amryt Pharma to Acquire Chiasma, Inc. to Further Strengthen Global Leadership in Rare and Orphan Diseases
- Combined business will have three approved commercial products, lomitapide (Lojuxta®/Juxtapid®), metreleptin (Myalept®/ Myalepta®), octreotide (MYCAPSSA®) and a robust clinical...
Vericel Reports First Quarter 2021 Financial Results and Raises Full-Year 2021 Revenue Guidance
First Quarter Total Net Revenue Increased 30% to $34.6 Million Full-Year 2021 Revenue Guidance Raised to $165-$168 Million Conference Call...
Model N and Channelnomics Announce Strategic Partnership
Leader in high tech revenue management teams with strategy and research firm to drive improved channel performance using Model N...
athenahealth Wins Three Stevie® Awards for its Provider-Facing Mobile Application in 2021 American Business Awards
athenaOne® Mobile App earns gold in “Integrated Mobile Experience” and bronze in “Health” and “Best User Experience” within the Mobile...
Establishment Labs Reports Record First Quarter 2021 Financial Results and Raises Full Year Guidance
SANTA BARBARA, Calif.--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the...
LENSAR Reports First Quarter 2021 Financial Results and Provides Business Update
First Quarter 2021 Procedure Volumes Increase 21.1% over First Quarter 2020 Cash and Cash Equivalents of $35.9 Million as of...
PeraHealth and BARDA Announce Partnership to Improve COVID-19 Patient Triage
The Rothman Index provides innovative solution for emergency department as newest member of BARDA’S DRIVe Medical countermeasures portfolio CHARLOTTE, N.C.--(BUSINESS...
NeoGenomics to Acquire Inivata – Combining Best-In-Class Liquid Biopsy Technology with Leading Community Oncology Platform
Establishes NeoGenomics as a technology leader in the minimal residual disease (MRD) testing market NeoGenomics exercises option struck in May...
NervGen Pharma Corp. Announces Overnight Marketed Equity Offering
Vancouver, British Columbia--(Newsfile Corp. - May 4, 2021) - NervGen Pharma Corp. (TSXV: NGEN) (OTCQX: NGENF) ("NervGen" the "Company"), a...
Inogen Announces First Quarter 2021 Financial Results
– Q1 2021 Total Revenue of $86.9 million – – Q1 2021 Rental Revenue of $9.9 million, up 84.2% from...
Core One Labs Unaware of Any Material Change that Would Account for Significant Share Price Depreciation
VANCOUVER, BC / ACCESSWIRE / May 4, 2021 / Core One Labs Inc. (CSE:COOL)(OTC PINK:CLABF)(Frankfurt:LD62) (WKN: A2P8K3) (the "Company" or...
Beacon Oral Specialists Appoints Michael Friguletto as CEO
DALLAS, TX / ACCESSWIRE / May 4, 2021 / Beacon Oral Specialists has appointed Michael Friguletto as its CEO effective immediately....